Page last updated: 2024-08-21

evans blue and docetaxel anhydrous

evans blue has been researched along with docetaxel anhydrous in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bougnoux, P; Champeroux, P; Chevalier, S; Goupille, C; Kornfeld, S; Lebeau, J; Mahéo, K; Martel, E; Maurin, A; Pinet, A; Richard, S; Tranquart, F; Vibet, S1

Other Studies

1 other study(ies) available for evans blue and docetaxel anhydrous

ArticleYear
Reducing endothelial NOS activation and interstitial fluid pressure with n-3 PUFA offset tumor chemoresistance.
    Carcinogenesis, 2012, Volume: 33, Issue:2

    Topics: Animals; Cell Movement; Cells, Cultured; Coloring Agents; Disease Progression; Docetaxel; Docosahexaenoic Acids; Drug Resistance, Neoplasm; Eicosapentaenoic Acid; Endothelial Cells; Evans Blue; Extracellular Fluid; Fatty Acids, Omega-3; Female; Human Umbilical Vein Endothelial Cells; Humans; Mammary Neoplasms, Animal; Neoplasm Metastasis; Neovascularization, Physiologic; Nitric Oxide Synthase Type III; Permeability; Phosphorylation; Rats; Rats, Sprague-Dawley; Signal Transduction; Taxoids; Vascular Endothelial Growth Factor A

2012